PL376866A1 - Nowe antagonistyczne pochodne receptora witronektyny, sposób ich przygotowania, ich zastosowanie jako leków i kompozycje farmaceutyczne je zawierające - Google Patents

Nowe antagonistyczne pochodne receptora witronektyny, sposób ich przygotowania, ich zastosowanie jako leków i kompozycje farmaceutyczne je zawierające

Info

Publication number: PL376866A1
Authority: PL; Poland
Prior art keywords: same; medicines; pharmaceutical compositions; compositions containing; receptor antagonist
Prior art date: 2002-11-19

Application number

PL376866A

Other languages

English (en)

Inventor

Jean-Marie Ruxer

Jean-Michel Lefrancois

Bertrand Heckmann

Original Assignee

Proskelia Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-19

Filing date

2003-11-12

Publication date

2006-01-09

2003-11-12 Application filed by Proskelia Sas filed Critical Proskelia Sas

2006-01-09 Publication of PL376866A1 publication Critical patent/PL376866A1/pl

Links

102100022337 Integrin alpha-V Human genes 0.000 title 1
108010048673 Vitronectin Receptors Proteins 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL376866A 2002-11-19 2003-11-12 Nowe antagonistyczne pochodne receptora witronektyny, sposób ich przygotowania, ich zastosowanie jako leków i kompozycje farmaceutyczne je zawierające PL376866A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0214429A FR2847254B1 (fr)	2002-11-19	2002-11-19	Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant

Publications (1)

Publication Number	Publication Date
PL376866A1 true PL376866A1 (pl)	2006-01-09

Family

ID=32187700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL376866A PL376866A1 (pl)	2002-11-19	2003-11-12	Nowe antagonistyczne pochodne receptora witronektyny, sposób ich przygotowania, ich zastosowanie jako leków i kompozycje farmaceutyczne je zawierające

Country Status (27)

Country	Link
US (2)	US7582640B2 (pl)
EP (2)	EP1565467B1 (pl)
JP (1)	JP4567459B2 (pl)
KR (1)	KR101140752B1 (pl)
CN (2)	CN101928287A (pl)
AR (2)	AR042068A1 (pl)
AT (2)	ATE431825T1 (pl)
AU (2)	AU2003299330B2 (pl)
BR (1)	BR0316307A (pl)
CA (1)	CA2506310C (pl)
CO (1)	CO5700761A2 (pl)
CY (1)	CY1112218T1 (pl)
DE (1)	DE60327712D1 (pl)
DK (2)	DK2070914T3 (pl)
ES (2)	ES2325616T3 (pl)
FR (1)	FR2847254B1 (pl)
IL (2)	IL168136A (pl)
MA (1)	MA27492A1 (pl)
MX (1)	MXPA05005340A (pl)
NO (1)	NO20052491L (pl)
PL (1)	PL376866A1 (pl)
PT (2)	PT1565467E (pl)
RU (1)	RU2412185C2 (pl)
SI (2)	SI2070914T1 (pl)
TW (1)	TW200412969A (pl)
WO (1)	WO2004048375A1 (pl)
ZA (1)	ZA200502850B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2847254B1 (fr)	2002-11-19	2005-01-28	Aventis Pharma Sa	Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
FR2870541B1 (fr)	2004-05-18	2006-07-14	Proskelia Sas	Derives de pyrimidines antigonistes du recepteur de la vitronectine
US20110189174A1 (en) *	2010-02-01	2011-08-04	Afshin Shafiee	Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
US20110237605A1 (en) *	2010-03-26	2011-09-29	Eric Phillips	Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative
MX2021001786A (es)	2018-08-17	2021-07-02	Oxurion NV	Antagonistas de integrina.
WO2021165206A1 (en)	2020-02-19	2021-08-26	Oxurion NV	Treatment of dry amd with integrin antagonists
EP4171212A4 (en)	2020-06-29	2024-07-24	Ickovic & Bliss, Inc.	Systems, methods, and program products for digital pet identification

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5217994A (en)	1991-08-09	1993-06-08	Merck & Co., Inc.	Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
US5204350A (en)	1991-08-09	1993-04-20	Merck & Co., Inc.	Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives
JP3322878B2 (ja)	1992-10-14	2002-09-09	メルクエンドカンパニーインコーポレーテッド	フィブリノーゲンレセプターアンタゴニスト
CA2150550A1 (en)	1992-12-01	1994-06-09	Melissa S. Egbertson	Fibrinogen receptor antagonists
JPH10501222A (ja)	1994-05-27	1998-02-03	メルクエンドカンパニーインコーポレーテッド	破骨細胞仲介骨吸収を抑制するための化合物
EP0762882A4 (en) *	1994-06-29	2002-09-11	Smithkline Beecham Corp	Vibronectin Receptor Antagonists
JPH10504808A (ja)	1994-06-29	1998-05-12	スミスクライン・ビーチャム・コーポレイション	ビトロネクチン受容体拮抗物質
SK176898A3 (en)	1996-06-28	1999-05-07	Merck Patent Gmbh	Phenylalamine derivatives as integrin inhibitors
DE19629816A1 (de) *	1996-07-24	1998-01-29	Hoechst Ag	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653646A1 (de) *	1996-12-20	1998-06-25	Hoechst Ag	Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
US6723727B1 (en)	1996-12-20	2004-04-20	Hoechst Aktiengesellschaft	Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
DE19705450A1 (de) *	1997-02-13	1998-08-20	Merck Patent Gmbh	Bicyclische aromatische Aminosäuren
EP0933367A1 (en) *	1997-12-19	1999-08-04	Hoechst Marion Roussel Deutschland GmbH	Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
IL137423A0 (en)	1998-01-23	2001-07-24	Aventis Pharma Gmbh	Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
CA2333927A1 (en) *	1998-04-01	1999-10-07	Dupont Pharmaceuticals Company	Pyrimidines and triazines as integrin antagonists
KR20010086355A (ko) *	1998-08-07	2001-09-10	스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스	비트로넥틴 수용체 길항제
AU748949B2 (en)	1999-06-23	2002-06-13	Merck & Co., Inc.	Integrin receptor antagonists
EP1065208A1 (en) *	1999-07-02	2001-01-03	Aventis Pharma Deutschland GmbH	Substituted purine derivatives as inhibitors of cell adhesion
EP1065207A1 (en)	1999-07-02	2001-01-03	Aventis Pharma Deutschland GmbH	Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
EP1218095B1 (en) *	1999-10-05	2003-09-03	Element Six (Pty) Ltd	Growth of diamond clusters
DE10042655A1 (de) *	2000-08-31	2002-03-14	Aventis Pharma Gmbh	Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
FR2847254B1 (fr)	2002-11-19	2005-01-28	Aventis Pharma Sa	Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
FR2870541B1 (fr) *	2004-05-18	2006-07-14	Proskelia Sas	Derives de pyrimidines antigonistes du recepteur de la vitronectine

2002
- 2002-11-19 FR FR0214429A patent/FR2847254B1/fr not_active Expired - Fee Related
2003
- 2003-11-12 CN CN2009101705723A patent/CN101928287A/zh active Pending
- 2003-11-12 RU RU2005119163/04A patent/RU2412185C2/ru not_active Application Discontinuation
- 2003-11-12 US US10/536,028 patent/US7582640B2/en active Active
- 2003-11-12 DE DE60327712T patent/DE60327712D1/de not_active Expired - Lifetime
- 2003-11-12 CN CN2003801088984A patent/CN1738817B/zh not_active Expired - Fee Related
- 2003-11-12 ES ES03799611T patent/ES2325616T3/es not_active Expired - Lifetime
- 2003-11-12 DK DK09003174.1T patent/DK2070914T3/da active
- 2003-11-12 PT PT03799611T patent/PT1565467E/pt unknown
- 2003-11-12 SI SI200332048T patent/SI2070914T1/sl unknown
- 2003-11-12 JP JP2004554592A patent/JP4567459B2/ja not_active Expired - Fee Related
- 2003-11-12 EP EP03799611A patent/EP1565467B1/fr not_active Expired - Lifetime
- 2003-11-12 PL PL376866A patent/PL376866A1/pl not_active Application Discontinuation
- 2003-11-12 MX MXPA05005340A patent/MXPA05005340A/es active IP Right Grant
- 2003-11-12 AT AT03799611T patent/ATE431825T1/de active
- 2003-11-12 AT AT09003174T patent/ATE518842T1/de active
- 2003-11-12 BR BR0316307-5A patent/BR0316307A/pt not_active IP Right Cessation
- 2003-11-12 EP EP09003174A patent/EP2070914B1/fr not_active Expired - Lifetime
- 2003-11-12 SI SI200331636T patent/SI1565467T1/sl unknown
- 2003-11-12 KR KR1020057009101A patent/KR101140752B1/ko not_active Expired - Fee Related
- 2003-11-12 AU AU2003299330A patent/AU2003299330B2/en not_active Ceased
- 2003-11-12 PT PT09003174T patent/PT2070914E/pt unknown
- 2003-11-12 WO PCT/FR2003/003349 patent/WO2004048375A1/fr not_active Ceased
- 2003-11-12 CA CA2506310A patent/CA2506310C/fr not_active Expired - Lifetime
- 2003-11-12 ES ES09003174T patent/ES2369561T3/es not_active Expired - Lifetime
- 2003-11-12 DK DK03799611T patent/DK1565467T3/da active
- 2003-11-13 TW TW092131850A patent/TW200412969A/zh unknown
- 2003-11-18 AR ARP030104254A patent/AR042068A1/es unknown
2005
- 2005-04-07 ZA ZA200502850A patent/ZA200502850B/en unknown
- 2005-04-19 IL IL168136A patent/IL168136A/en active IP Right Grant
- 2005-05-12 MA MA28281A patent/MA27492A1/fr unknown
- 2005-05-16 CO CO05046617A patent/CO5700761A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052491A patent/NO20052491L/no not_active Application Discontinuation
2008
- 2008-10-03 US US12/245,622 patent/US7763621B2/en not_active Expired - Fee Related
2009
- 2009-08-24 AU AU2009212779A patent/AU2009212779B2/en not_active Ceased
2010
- 2010-05-11 IL IL205693A patent/IL205693A/en active IP Right Grant
- 2010-07-15 AR ARP100102568A patent/AR077476A2/es not_active Application Discontinuation
2011
- 2011-11-02 CY CY20111101051T patent/CY1112218T1/el unknown

Also Published As

Publication number	Publication date
JP2006508999A (ja)	2006-03-16
CY1112218T1 (el)	2015-12-09
HK1129372A1 (en)	2009-11-27
NO20052491D0 (no)	2005-05-23
FR2847254A1 (fr)	2004-05-21
KR20050083926A (ko)	2005-08-26
AU2009212779B2 (en)	2011-09-01
PT1565467E (pt)	2009-07-15
ATE518842T1 (de)	2011-08-15
IL168136A (en)	2012-06-28
BR0316307A (pt)	2005-09-27
FR2847254B1 (fr)	2005-01-28
US7582640B2 (en)	2009-09-01
CN101928287A (zh)	2010-12-29
CA2506310A1 (fr)	2004-06-10
AU2003299330A1 (en)	2004-06-18
CA2506310C (fr)	2014-04-08
ES2369561T3 (es)	2011-12-01
CO5700761A2 (es)	2006-11-30
EP1565467A1 (fr)	2005-08-24
JP4567459B2 (ja)	2010-10-20
MXPA05005340A (es)	2005-11-17
MA27492A1 (fr)	2005-08-01
US7763621B2 (en)	2010-07-27
EP2070914B1 (fr)	2011-08-03
RU2005119163A (ru)	2006-02-27
DE60327712D1 (de)	2009-07-02
US20060052398A1 (en)	2006-03-09
SI1565467T1 (sl)	2009-10-31
PT2070914E (pt)	2011-10-12
CN1738817A (zh)	2006-02-22
TW200412969A (en)	2004-08-01
SI2070914T1 (sl)	2012-02-29
NO20052491L (no)	2005-05-23
EP2070914A1 (fr)	2009-06-17
AR077476A2 (es)	2011-08-31
CN1738817B (zh)	2011-12-21
WO2004048375A1 (fr)	2004-06-10
ATE431825T1 (de)	2009-06-15
EP1565467B1 (fr)	2009-05-20
KR101140752B1 (ko)	2012-05-03
ES2325616T3 (es)	2009-09-10
HK1076277A1 (en)	2006-01-13
AU2009212779A1 (en)	2009-09-17
AR042068A1 (es)	2005-06-08
US20090149476A1 (en)	2009-06-11
RU2412185C2 (ru)	2011-02-20
AU2003299330B2 (en)	2009-09-17
DK1565467T3 (da)	2009-09-14
ZA200502850B (en)	2005-10-25
IL205693A (en)	2011-06-30
DK2070914T3 (da)	2011-11-21

Legal Events

Date	Code	Title	Description
2014-05-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
HUP0400570A3 (en)	2004-09-28	Phenylethenyl or phenylethinyl heteroaril derivatives as glutamate receptor antagonists, their use, process for their preparation and pharmaceutical compositions containing them
HUP0402588A3 (en)	2009-09-28	Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
IL163831A (en)	2010-12-30	Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
HUP0300138A3 (en)	2003-06-30	Cyclic amine derivatives as ccr5 antagonists, their production and use and pharmaceutical compositions containing them
HUP0202787A3 (en)	2003-12-29	Piperazine derivatives as 5-ht1b antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0200139A3 (en)	2003-01-28	3-phenylpyridine derivatives and their use as nk-1 receptor antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0400989A3 (en)	2011-08-29	Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
IL169818A0 (en)	2007-07-04	Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
MXPA03006538A (es)	2003-09-22	Nuevos derivados de urea, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
HUP0200438A3 (en)	2003-10-28	Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0300052A3 (en)	2004-03-01	Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists, process for their preparation and pharmaceutical compositions containing them
PL1720544T3 (pl)	2008-05-30	Nowe pochodne azabicykliczne, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
HUP0101143A3 (en)	2002-12-28	Pyridin-carboxylic acid derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
HUP0201571A3 (en)	2002-11-28	Il-8 receptor antagonist phenyl urea derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP0003641A3 (en)	2002-10-28	Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
HUP0203976A3 (en)	2004-08-30	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en)	2003-10-13	Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201710A3 (en)	2002-11-28	Biphenyl derivatives as antagonists of the neurokinine-1 receptor, process for producing them and pharmaceutical compositions containing them
HUP0104804A3 (en)	2002-12-28	Tetrahydro-naphthyridinyl derivative as vitronectin receptor antagonist, process for its preparation and pharmaceutical composition containing the same
PL376866A1 (pl)	2006-01-09	Nowe antagonistyczne pochodne receptora witronektyny, sposób ich przygotowania, ich zastosowanie jako leków i kompozycje farmaceutyczne je zawierające
HUP0202706A3 (en)	2004-12-28	Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them
HUP0500958A3 (en)	2009-12-28	2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
IL158660A0 (en)	2004-05-12	Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
HUP0300694A3 (en)	2005-08-29	Indole derivatives as mcp-1 receptor antagonists, their use, process for their preparation and pharmaceutical compositions containing them
HUP0103090A3 (en)	2002-12-28	Vitronectin receptor antagonist oxazole derivatives, process for their preparation, pharmaceutical compositions containing them and their use